Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ADVISORY, May 27, 2015 (GLOBE NEWSWIRE) -- What: Solar3D, Inc. (Nasdaq:SLTD), a leading provider of solar power solutions, will visit the Nasdaq MarketSite in Times Square. In honor of...
-
ADVISORY, May 27, 2015 (GLOBE NEWSWIRE) -- What: Overstock.com, Inc. (Nasdaq:OSTK), an online shopping retailer based in Salt Lake City, Utah that sells a broad range of products at low...
-
CHARLOTTE, N.C., May 27, 2015 (GLOBE NEWSWIRE) -- Premier, Inc. (Nasdaq:PINC), a leading healthcare improvement company, today announced that its Chief Operating Officer Michael J. Alkire will present...
-
NEW YORK, May 27, 2015 (GLOBE NEWSWIRE) -- WisdomTree Investments, Inc. (Nasdaq:WETF), an exchange-traded fund ("ETF") and exchange-traded product ("ETP") sponsor and asset manager, today announced...
-
G1T28 produced robust, transient, G1 cell cycle arrest of bone marrow cells Compound was well tolerated with predictable pharmacokinetic / pharmacodynamic activity Data support...
-
SANTA MONICA, Calif., May 27, 2015 (GLOBE NEWSWIRE) -- TrueCar, Inc. (Nasdaq:TRUE), the negotiation-free car buying and selling mobile marketplace, today announced that TrueCar management will...
-
TYSONS CORNER, Va., May 27, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical...
-
CEDAR KNOLLS, N.J., May 27, 2015 (GLOBE NEWSWIRE) -- Sears Hometown and Outlet Stores, Inc. (Nasdaq:SHOS) announces the opening of a new Sears Outlet Store located at 235 Ridgedale Ave. in Cedar...
-
CAMBRIDGE, Ma. and EXTON, Pa., May 27, 2015 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics...
-
REDWOOD CITY, Calif., May 27, 2015 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), a leading pure-play, global biosimilars company with late-stage clinical products, today announced that...